Investing.com-- Shares of Telix Pharmaceuticals (ASX:TLX) jumped on Tuesday after the company reported positive results from a late-stage trial of its experimental prostate cancer therapy.
Stockhead on MSN
Health check: Telix jumps first hurdle with its advanced prostate cancer therapy trial
In welcome good news, Telix says the first stage of its pivotal prostate cancer therapeutic trial has hit its desired safety ...
The news: Shares in Telix Pharmaceutical climbed in morning trade after the company reported positive results from a global phase 3 trial of its advanced prostate cancer treatment, TLX591. Shares ...
Philstar Life on MSN
Vegetarian diet lowers risk to five types of cancers—study
A vegetarian diet can lower your risk of many cancers! According to a study from the University of Oxford, vegetarians have lower risks of five types of cancers: pancreatic, breast, kidney, prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results